Disclosure Of First-Time Adoption [Text Block]

ABIONYX Pharma - Filing #879713

Concept As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
201,000 EUR
169 829 EUR
10 677 EUR
10,000 EUR
179 214 EUR
87,000 EUR
1 396 EUR
1 232 EUR
5,000 EUR
136,000 EUR
39,000 EUR
164 822 EUR
170 322 EUR
6 629 EUR
110,000 EUR
1 097 EUR
163 034 EUR
6 666 EUR
168 621 EUR
92,000 EUR
Comprehensive income
5 759 EUR
1 891 EUR
Profit (loss)
5 822 EUR
5 822 EUR
1 886 EUR
1 886 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.